Rye Brook Capital LLC: IBIT position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Rye Brook Capital LLC on IBIT, newest first. How the timeline and the estimate are built.
Rye Brook Capital LLC held 56,550 IBIT shares at 2026-09-30 per its 13F-HR filed 2026-10-07.
the latest 13F is the newest step
- period ended2026-09-3013F 56,550 sharesChange vs previous 13F +2,320 shares
1.73% of the 13F portfolio, value $2,677,000.
13F-HR 0001844147-26-000004 filed by Rye Brook Capital LLC
Accepted , ingested - period ended2026-06-3013F 54,230 sharesChange vs previous 13F +2,120 shares
1.27% of the 13F portfolio, value $1,805,000.
13F-HR 0001844147-26-000003 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 52,110 sharesChange vs previous 13F +7,410 shares
1.85% of the 13F portfolio, value $2,002,000.
13F-HR 0001844147-26-000002 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 44,700 sharesChange vs previous 13F +2,700 shares
2.07% of the 13F portfolio, value $2,219,000.
13F-HR 0001844147-26-000001 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 42,000 sharesChange vs previous 13F +20,100 shares
2.3% of the 13F portfolio, value $2,730,000.
13F-HR 0001844147-25-000005 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 21,900 sharesChange vs previous 13F not available
1.4% of the 13F portfolio, value $1,340,000.
13F-HR 0001844147-25-000003 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).